The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
As STAT’s Katie Palmer reports in a new story, the lack of standards for collection of this information will make it more ...
The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...